GGrantIndex
← Leaderboards

Hans-Guido Wendel

Sloan-Kettering Inst Can Research

$13,517,904
Attributed
$14,850,792
Total exposure
7
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.4M · FY201025
$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$14,850,792 · 7

By mechanism

R01$9,655,040 · 5
R35$5,182,716 · 1
P41$13,036 · 1

Top collaborators

Most similar at Sloan-Kettering Inst Can Research

Same institution · by research overlap

Others in their field

Top investigators on “Mouse Model

Research focus

Mouse ModelBaseLymphomaPublic Health RelevanceFollicular LymphomaAffectInhibitor/AntagonistMalignant NeoplasmsBiologyGeneticMalignant - DescriptorMolecularCellsReportingPathogenesisInsightGenesTranslationsBcl2 GeneNovel TherapeuticsB-Cell LymphomasEzh2 GeneEpigenetic ProcessTumor

Grant awards (28)

Towards targeting the lymphoma microenvironment$1,062,000
R35 · FY2025 · CA · contact PI
Towards targeting the lymphoma microenvironment$1,008,898
R35 · FY2024 · CA · contact PI
Towards targeting the lymphoma microenvironment$908,577
R35 · FY2023 · CA · contact PI
Towards targeting the lymphoma microenvironment$1,040,760
R35 · FY2022 · CA · contact PI
Towards targeting the lymphoma microenvironment$1,062,000
R35 · FY2021 · CA · contact PI
Exploring the link between serine metabolism and epigenetic in lymphoma$569,395
R01 · FY2020 · CA · contact PI
Exploring oncogenic translation programs in cancer$426,103
R01 · FY2020 · CA · contact PI
Towards targeting the lymphoma microenvironment$100,481
R35 · FY2020 · CA · contact PI
The genomic pathogenesis of Follicular Lymphoma$504,983
R01 · FY2019 · CA
Exploring oncogenic translation programs in cancer$413,319
R01 · FY2019 · CA · contact PI
The genomic pathogenesis of Follicular Lymphoma$520,601
R01 · FY2018 · CA
Towards The Chemotherapy-Free Treatment of Follicular Lymphoma$475,801
R01 · FY2018 · CA · contact PI
Exploring oncogenic translation programs in cancer$406,648
R01 · FY2018 · CA · contact PI
The genomic pathogenesis of Follicular Lymphoma$541,994
R01 · FY2017 · CA
Towards The Chemotherapy-Free Treatment of Follicular Lymphoma$475,801
R01 · FY2017 · CA · contact PI
Exploring oncogenic translation programs in cancer$406,648
R01 · FY2017 · CA · contact PI
The genomic pathogenesis of Follicular Lymphoma$541,994
R01 · FY2016 · CA
Towards The Chemotherapy-Free Treatment of Follicular Lymphoma$475,801
R01 · FY2016 · CA · contact PI
Exploring oncogenic translation programs in cancer$406,648
R01 · FY2016 · CA · contact PI
The genomic pathogenesis of Follicular Lymphoma$556,205
R01 · FY2015 · CA
Towards The Chemotherapy-Free Treatment of Follicular Lymphoma$475,801
R01 · FY2015 · CA · contact PI
Towards The Chemotherapy-Free Treatment of Follicular Lymphoma$567,773
R01 · FY2014 · CA · contact PI
The contribution of protein translation to tumorigenesis$370,951
R01 · FY2014 · CA · contact PI
The contribution of protein translation to tumorigenesis$359,478
R01 · FY2013 · CA · contact PI
The contribution of protein translation to tumorigenesis$382,423
R01 · FY2012 · CA · contact PI
The contribution of protein translation to tumorigenesis$382,423
R01 · FY2011 · CA · contact PI
STRUCTURE FUNCTION STUDY OF A NOVEL TUMOR SUPPRESSOR, EPHA$13,036
P41 · FY2011 · RR · contact PI
The contribution of protein translation to tumorigenesis$394,250
R01 · FY2010 · CA · contact PI